Suppr超能文献

脑胶质瘤干细胞的侵袭潜能升高。

Elevated invasive potential of glioblastoma stem cells.

机构信息

Center for Experimental Research, The First People's Hospital, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Biochem Biophys Res Commun. 2011 Mar 25;406(4):643-8. doi: 10.1016/j.bbrc.2011.02.123. Epub 2011 Mar 1.

Abstract

Glioblastomas (GBMs) are the most lethal and common types of primary brain tumors. The hallmark of GBMs is their highly infiltrative nature. The cellular and molecular mechanisms underlying the aggressive cancer invasion in GBMs are poorly understood. GBM displays remarkable cellular heterogeneity and hierarchy containing self-renewing glioblastoma stem cells (GSCs). Whether GSCs are more invasive than non-stem tumor cells and contribute to the invasive phenotype in GBMs has not been determined. Here we provide experimental evidence supporting that GSCs derived from GBM surgical specimens or xenografts display greater invasive potential in vitro and in vivo than matched non-stem tumor cells. Furthermore, we identified several invasion-associated proteins that were differentially expressed in GSCs relative to non-stem tumor cells. One of such proteins is L1CAM, a cell surface molecule shown to be critical to maintain GSC tumorigenic potential in our previous study. Immunohistochemical staining showed that L1CAM is highly expressed in a population of cancer cells in the invasive fronts of primary GBMs. Collectively, these data demonstrate the invasive nature of GSCs, suggesting that disrupting GSCs through a specific target such as L1CAM may reduce GBM cancer invasion and tumor recurrence.

摘要

胶质母细胞瘤(GBM)是最致命和最常见的原发性脑肿瘤。GBM 的标志是其高度浸润性。GBM 中侵袭性癌症侵袭的细胞和分子机制尚未完全了解。GBM 表现出明显的细胞异质性和层次结构,包含自我更新的胶质母细胞瘤干细胞(GSCs)。GSCs 是否比非干细胞肿瘤细胞更具侵袭性,并有助于 GBM 中的侵袭表型尚未确定。在这里,我们提供了实验证据,支持源自 GBM 手术标本或异种移植物的 GSCs 在体外和体内比匹配的非干细胞肿瘤细胞具有更大的侵袭潜力。此外,我们鉴定了一些在 GSCs 中相对于非干细胞肿瘤细胞差异表达的侵袭相关蛋白。其中一种蛋白是 L1CAM,是我们之前的研究中表明对维持 GSC 肿瘤发生潜能至关重要的细胞表面分子。免疫组织化学染色显示,L1CAM 在原发性 GBM 侵袭前沿的一群癌细胞中高度表达。总之,这些数据表明 GSCs 具有侵袭性,表明通过 L1CAM 等特定靶标破坏 GSCs 可能会降低 GBM 癌症侵袭和肿瘤复发的风险。

相似文献

1
Elevated invasive potential of glioblastoma stem cells.
Biochem Biophys Res Commun. 2011 Mar 25;406(4):643-8. doi: 10.1016/j.bbrc.2011.02.123. Epub 2011 Mar 1.
2
Targeting role of glioma stem cells for glioblastoma multiforme.
Curr Med Chem. 2013;20(15):1974-84. doi: 10.2174/0929867311320150004.
4
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
Neuro Oncol. 2012 Feb;14(2):132-44. doi: 10.1093/neuonc/nor195. Epub 2011 Nov 7.
5
Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.
Protein Cell. 2010 Jul;1(7):638-55. doi: 10.1007/s13238-010-0078-y. Epub 2010 Jul 29.
6
L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.
EMBO J. 2011 Mar 2;30(5):800-13. doi: 10.1038/emboj.2011.10. Epub 2011 Feb 4.
7
Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
PLoS One. 2015 May 8;10(5):e0125838. doi: 10.1371/journal.pone.0125838. eCollection 2015.
8
The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Cell Death Differ. 2015 Sep;22(9):1517-25. doi: 10.1038/cdd.2015.7. Epub 2015 Feb 27.
9
The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
Int J Mol Sci. 2021 Apr 8;22(8):3863. doi: 10.3390/ijms22083863.
10
Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Oncotarget. 2015 Nov 10;6(35):37300-15. doi: 10.18632/oncotarget.5836.

引用本文的文献

3
Takeaways from meta-analysis: indications of combinational treatments for glioblastoma.
J Neurooncol. 2025 Aug 21. doi: 10.1007/s11060-025-05205-8.
4
Natural Compounds That Target Glioma Stem Cells.
NeuroSci. 2025 Jun 5;6(2):52. doi: 10.3390/neurosci6020052.
5
Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2.
Cell Metab. 2024 Nov 5;36(11):2419-2436.e8. doi: 10.1016/j.cmet.2024.09.014. Epub 2024 Oct 24.
6
Targeting glioblastoma with a brain-penetrant drug that impairs brain tumor stem cells via NLE1-Notch1 complex.
Stem Cell Reports. 2024 Nov 12;19(11):1534-1547. doi: 10.1016/j.stemcr.2024.09.007. Epub 2024 Oct 17.
8
The role of lactate-induced protein lactylation in gliomas: implications for preclinical research and the development of new treatments.
Front Pharmacol. 2024 Jun 25;15:1383274. doi: 10.3389/fphar.2024.1383274. eCollection 2024.
9
Dissecting TGF-β-induced glioblastoma invasion with engineered hyaluronic acid hydrogels.
APL Bioeng. 2024 Jun 13;8(2):026125. doi: 10.1063/5.0203213. eCollection 2024 Jun.
10
Glioblastoma modeling with 3D organoids: progress and challenges.
Oxf Open Neurosci. 2023 Jul 6;2:kvad008. doi: 10.1093/oons/kvad008. eCollection 2023.

本文引用的文献

1
L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.
EMBO J. 2011 Mar 2;30(5):800-13. doi: 10.1038/emboj.2011.10. Epub 2011 Feb 4.
2
Potential therapeutic implications of cancer stem cells in glioblastoma.
Biochem Pharmacol. 2010 Sep 1;80(5):654-65. doi: 10.1016/j.bcp.2010.04.035. Epub 2010 May 10.
3
Medical oncology: treatment and management of malignant gliomas.
Nat Rev Clin Oncol. 2010 Feb;7(2):75-7. doi: 10.1038/nrclinonc.2009.221.
4
The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration.
J Biol Chem. 2010 Jan 22;285(4):2463-73. doi: 10.1074/jbc.M109.055129. Epub 2009 Nov 13.
6
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.
Cancer Cell. 2009 Jun 2;15(6):501-13. doi: 10.1016/j.ccr.2009.03.018.
7
microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.
Brain Res. 2009 May 7;1269:158-65. doi: 10.1016/j.brainres.2009.02.037. Epub 2009 Mar 3.
9
L1 cell adhesion molecule (L1CAM) in invasive tumors.
Cancer Lett. 2009 Sep 18;282(2):137-45. doi: 10.1016/j.canlet.2008.12.021. Epub 2009 Jan 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验